lead has been researched along with Tauopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alansi, B; Bihaqi, SW; Masoud, AM; Mushtaq, F; Subaiea, GM; Zawia, NH | 1 |
| Haraguchi, T; Horike, T; Ikeda, K; Ishizu, H; Kawai, K; Kira, S; Kuroda, S; Morita, K; Takehisa, Y; Terada, S; Tsuchiya, K; Yokota, O | 1 |
2 other study(ies) available for lead and Tauopathies
| Article | Year |
|---|---|
Influence of Early Life Lead (Pb) Exposure on α-Synuclein, GSK-3β and Caspase-3 Mediated Tauopathy: Implications on Alzheimer's Disease.
Topics: alpha-Synuclein; Animals; Caspase 3; Cell Line, Tumor; Disease Models, Animal; Glycogen Synthase Kinase 3 beta; Green Fluorescent Proteins; Humans; Lead; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuroblastoma; tau Proteins; Tauopathies; Up-Regulation | 2018 |
Lead content of brain tissue in diffuse neurofibrillary tangles with calcification (DNTC): the possibility of lead neurotoxicity.
Topics: Aged; Brain; Calcinosis; Female; Fixatives; Formaldehyde; Freezing; Humans; Lead; Lead Poisoning, Nervous System; Male; Middle Aged; Neurofibrillary Tangles; Spectrophotometry, Atomic; Tauopathies | 2001 |